Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Myeloproliferative Neoplasms and The 2022 Tandem Meetings

The MPN Channel on VJHemOnc is supported by Kartos Therapeutics, Inc.. This supporter has no influence over the production of the content.

3:30
Unmet needs in MF: managing anemia & improving the efficacy of first and second-line treatments
Srdan Verstovsek • 25 Apr 2022
3:02
Current and emerging management strategies in polycythemia vera
Srdan Verstovsek • 25 Apr 2022
2:26
Targeting chronic inflammation in MPNs
Srdan Verstovsek • 25 Apr 2022
3:43
Momelotinib: a promising drug for patients with myelofibrosis
Srdan Verstovsek • 25 Apr 2022
4:16
JAK inhibitor selection & sequencing in myelofibrosis
Srdan Verstovsek • 25 Apr 2022

The MPN Channel on VJHemOnc is supported by Kartos Therapeutics, Inc..

This supporter has no influence over the production of the content.

If you are interested in becoming a supporter of The MPN Channel, please contact us.

The content of VJHemOnc is intended for healthcare professionals